This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 92/5/1948    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ozawa, A. Articles by Marx, S. J. Search for Related Content PubMed PubMed Citation Articles by Ozawa, A. Articles by Marx, S. J. Related Collections Neuroendocrinology and Pituitary Calcium and Bone Metabolism Endocrine Oncology

The Parathyroid/Pituitary Variant of Multiple Endocrine Neoplasia Type 1 Usually Has Causes Other than p27^Kip1 Mutations

Metabolic Diseases Branch (A.O., S.K.A., C.M.M., A.L.B., T.S.R., P.A.K., C.M.Q., W.F.S., L.S.W., A.M.S., S.J.M.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), Bethesda, Maryland 20892; and Genome Technology Branch (S.C.C., F.S.C.), National Human Genome Research Institute, NIH, Bethesda, Maryland 20892

Address all correspondence and reprint requests to: Atsushi Ozawa, M.D., Ph.D., Building 10, Room 9C-103, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1802. E-mail: ozawaa{at}niddk.nih.gov.

Context: One variant of multiple endocrine neoplasia type 1 (MEN1) is defined by sporadic tumors of both the parathyroids and pituitary. The prevalence of identified MEN1 mutations in this variant is lower than in familial MEN1 (7% vs. 90%), suggesting different causes. Recently, one case of this variant had a germline mutation of p27^Kip1/CDKN1B.

Objective: The objective was to test p27 in germline DNA from cases with tumors of both the parathyroids and pituitary.

Design: Medical record review and sequence analysis in DNA were performed.

Setting: This study involved an inpatient and outpatient referral program for cases of endocrine tumors.

Patients: Sixteen index cases had sporadic tumors of two organs, both the parathyroids and the pituitary. There were 18 additional index cases with related features of familial tumors. Five subjects were normal controls. No case had an identified MEN1 mutation.

Interventions: Clinical status of endocrine tumors was tabulated. Sequencing of germline DNA from index cases and control cases for the p27 gene was performed by PCR.

Main Outcome Measures: Endocrine tumor types and their expressions were measured, as were sequence changes in the p27 gene.

Results: Tumor features were documented in index cases and families. One p27 germline single nucleotide change was identified. This predicted a silent substitution of Thr142Thr. Furthermore, there was a normal prevalence of heterozygosity for a common p27 polymorphism, making a large p27 deletion unlikely in all or most of these cases.

Conclusions: The MEN1 variant with sporadic parathyroid tumors, sporadic pituitary tumor, and no identified MEN1 mutation is usually not caused by p27 germline mutations. It is usually caused by as yet unknown process(es).